Tanno S - Search Results

1

Risk of additional pancreatic cancer in patients with branch duct intraductal papillary-mucinous neoplasm.

Tanno S, Obara T, Koizumi K, Nakano Y, Osanai M, Mizukami Y, Kohgo Y. Tanno S, et al. Clin J Gastroenterol. 2009 Dec;2(6):365-370. doi: 10.1007/s12328-009-0116-6. Epub 2009 Oct 30. Clin J Gastroenterol. 2009. PMID: 26192788

2

[Cholelithiasis].

Tanno S, Obara T, Kohgo Y. Tanno S, et al. Nihon Rinsho. 2002 Jan;60 Suppl 1:278-83. Nihon Rinsho. 2002. PMID: 11838127 Review. Japanese. No abstract available.

3

Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype.

Shibata N, Watari J, Fujiya M, Tanno S, Saitoh Y, Kohgo Y. Shibata N, et al. Among authors: tanno s. Hum Pathol. 2003 Jan;34(1):32-40. doi: 10.1053/hupa.2003.2. Hum Pathol. 2003. PMID: 12605364

4

PPAR gamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells.

Nagamine M, Okumura T, Tanno S, Sawamukai M, Motomura W, Takahashi N, Kohgo Y. Nagamine M, et al. Among authors: tanno s. Cancer Sci. 2003 Apr;94(4):338-43. doi: 10.1111/j.1349-7006.2003.tb01443.x. Cancer Sci. 2003. PMID: 12824901 Free PMC article.

5

Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.

Motomura W, Takahashi N, Nagamine M, Sawamukai M, Tanno S, Kohgo Y, Okumura T. Motomura W, et al. Among authors: tanno s. Int J Cancer. 2004 Jan 1;108(1):41-6. doi: 10.1002/ijc.11561. Int J Cancer. 2004. PMID: 14618613

6

Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells.

Habiro A, Tanno S, Koizumi K, Izawa T, Nakano Y, Osanai M, Mizukami Y, Okumura T, Kohgo Y. Habiro A, et al. Among authors: tanno s. Biochem Biophys Res Commun. 2004 Mar 26;316(1):71-7. doi: 10.1016/j.bbrc.2004.02.017. Biochem Biophys Res Commun. 2004. PMID: 15003513

7

Serine/threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance.

Tanno S, Yanagawa N, Habiro A, Koizumi K, Nakano Y, Osanai M, Mizukami Y, Okumura T, Testa JR, Kohgo Y. Tanno S, et al. Cancer Res. 2004 May 15;64(10):3486-90. doi: 10.1158/0008-5472.CAN-03-1788. Cancer Res. 2004. PMID: 15150102

8

Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells.

Motomura W, Nagamine M, Tanno S, Sawamukai M, Takahashi N, Kohgo Y, Okumura T. Motomura W, et al. Among authors: tanno s. J Gastroenterol. 2004;39(5):461-8. doi: 10.1007/s00535-003-1324-3. J Gastroenterol. 2004. PMID: 15175945

9

Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells.

Motomura W, Tanno S, Takahashi N, Nagamine M, Fukuda M, Kohgo Y, Okumura T. Motomura W, et al. Among authors: tanno s. Biochem Biophys Res Commun. 2005 Jun 24;332(1):89-94. doi: 10.1016/j.bbrc.2005.04.095. Biochem Biophys Res Commun. 2005. PMID: 15896303

10

Activation of p38 mitogen-activated protein kinase is necessary for gemcitabine-induced cytotoxicity in human pancreatic cancer cells.

Koizumi K, Tanno S, Nakano Y, Habiro A, Izawa T, Mizukami Y, Okumura T, Kohgo Y. Koizumi K, et al. Among authors: tanno s. Anticancer Res. 2005 Sep-Oct;25(5):3347-53. Anticancer Res. 2005. PMID: 16101149 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters